Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 9,999 shares at $83.07 ($846K) on 2026-07-13, disclosed to the SEC on 2026-07-13.
Scheduled sale ($846k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.07 | 300 | $25K | 2.9% |
| 2 | $84.26 | 3,743 | $315K | 37.3% |
| 3 | $84.90 | 5,656 | $480K | 56.7% |
| 4 | $85.63 | 300 | $26K | 3.0% |
| Total | $84.63 avg | 9,999 | $846K | 100% |
| Filing → |
| ORKA | SELL | 2026-08-14 | $1.1M | — | Filing → |
| ORKA | SELL | 2026-06-22 | $128K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $687K | — | Filing → |